The major players in the market include Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific(U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup(France), Mindray (China), Horiba (Japan).
Dallas, TX -- (SBWIRE) -- 11/19/2014 -- The “Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals) & by End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019” report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global clinical chemistry analyzers market along with the estimates and forecasts of the revenue and market share analysis.
The global clinical chemistry analyzers market was estimated at $8,965 million in 2014. This market is expected to grow at a CAGR of 5.52% between 2014 and 2019, to reach $11,728.01 million in 2019.
This report segment the clinical chemistry analyzer market on the basis of products, test, end users and regions. The product segments included in this report are analyzers, reagents and other products. The clinical chemistry analyzer product segment is further divided on the basis of type into four segments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), Very large (2,000 Tests/H). The reagents product segment is further categorized into calibrators, controls, standards and other reagents. The tests segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. The end-user segments included in this report are academic research institutes, diagnostic laboratories, hospitals, and other end users.
For Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=144027310
Rapid growth in the diagnostics market, increase in the healthcare spending, and increasing incidence in lifestyle disease will drive the growth of the market. Furthermore, increasing awareness for preventative healthcare, increase in aging population, increase in reagent rental agreements and increasing demand for laboratory automation will aid the demand for clinical chemistry analyzer products.
Speak to Research Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=144027310
The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW). The geographic analysis reveals that Americas accounted for the largest share in the global market in 2014. The BRIC regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for automation from this region.
The major players in the market include Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific (U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup(France), Mindray (China), Horiba (Japan).
Browse related reports:
Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets